Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Medical Devices
Health
Science
Research
Health Technology
First-Quarter 2025

More Like This

Business Wire logo

LivaNova Reports First-Quarter 2024 Results

Business Wire logo

LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

Business Wire logo

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

Business Wire logo

LivaNova Reports Second-Quarter 2024 Results

Business Wire logo

LivaNova Reports Third-Quarter 2024 Results

Business Wire logo

LivaNova Reports Third-Quarter 2023 Results

Business Wire logo

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Business Wire logo

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us